Isonimesulide and Its Carborane Analogues as Isoform‐Selective COX Inhibitors and Antitumor Agents
Advanced Therapeutics · 2023-08 · 6 (8)
DOI: 10.1002/adtp.202300117 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Therapeutics, online erschienen am 24.05.2023. Verfasst von Liridona Useini und 8 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Bundesministerium für Bildung und Forschung, Deutsche Forschungsgemeinschaft, Graduate School BuildMoNa.
Abstract (Originalsprache)
Nonsteroidal anti‐inflammatory drugs (NSAIDs) are the most widely used therapeutics against pain, fever, and inflammation; additionally, antitumor properties are reported. NSAIDs reduce the synthesis of prostaglandins by inhibiting the cyclooxygenase (COX) isoforms COX‐1 and COX‐2. As nonselective inhibition is associated with off‐target effects, strategies to achieve selectivity for the clinically preferred isoform COX‐2 are of high interest. The modification of NSAIDs using carborane clusters as phenyl mimetics is reported to alter the selectivity profile through size exclusion. Inspired by these findings, isonimesulide and its carborane derivatives are prepared. The biological screening shows that the carborane containing compounds exhibit a stronger antitumor potential compared to nimesulide and isonimesulide. Furthermore, the replacement of the phenyl ring of isonimesulide with a carborane moiety resulted in a shift of the COX activity from nonactive to COX‐active compounds.
Förderung
- Bundesministerium für Bildung und Forschung
- Deutsche Forschungsgemeinschaft
- Graduate School BuildMoNa
- Deutscher Akademischer Austauschdienst
Zitieren
APA
Useini, L., Komazec, T., Laube, M., Lönnecke, P., Schädlich, J., Mijatović, S., Maksimović‐Ivanić, D., Pietzsch, J., & Hey‐Hawkins, E. (2023). Isonimesulide and Its Carborane Analogues as Isoform‐Selective COX Inhibitors and Antitumor Agents. Advanced Therapeutics, 6(8). https://doi.org/10.1002/adtp.202300117
Vancouver
Useini L, Komazec T, Laube M, Lönnecke P, Schädlich J, Mijatović S, et al. Isonimesulide and Its Carborane Analogues as Isoform‐Selective COX Inhibitors and Antitumor Agents. Advanced Therapeutics. 2023;6(8). doi:10.1002/adtp.202300117
BibTeX
@article{Useini2023,
author = {Useini, Liridona and Komazec, Teodora and Laube, Markus and Lönnecke, Peter and Schädlich, Jonas and Mijatović, Sanja and Maksimović‐Ivanić, Danijela and Pietzsch, Jens and Hey‐Hawkins, Evamarie},
title = {Isonimesulide and Its Carborane Analogues as Isoform‐Selective COX Inhibitors and Antitumor Agents},
journal = {Advanced Therapeutics},
year = {2023},
volume = {6},
number = {8},
doi = {10.1002/adtp.202300117}
}
EUVIMED